A detailed history of W Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, W Advisors, LLC holds 2,357 shares of ABBV stock, worth $401,514. This represents 0.29% of its overall portfolio holdings.

Number of Shares
2,357
Previous 2,314 1.86%
Holding current value
$401,514
Previous $396,000 17.42%
% of portfolio
0.29%
Previous 0.26%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$163.84 - $199.33 $7,045 - $8,571
43 Added 1.86%
2,357 $465,000
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $3,560 - $4,157
23 Added 1.0%
2,314 $396,000
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $2,876 - $3,277
18 Added 0.79%
2,291 $417,000
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $7,017 - $7,903
51 Added 2.3%
2,273 $352,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $3,606 - $4,175
27 Added 1.23%
2,222 $331,000
Q2 2023

Aug 03, 2023

SELL
$132.51 - $164.9 $6,758 - $8,409
-51 Reduced 2.27%
2,195 $295,000
Q1 2023

Aug 07, 2023

SELL
$144.61 - $166.54 $144 - $166
-1 Reduced 0.05%
2,194 $349,000
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $7,607 - $9,122
55 Added 2.51%
2,246 $363,000
Q3 2022

Oct 24, 2022

SELL
$134.21 - $153.93 $402 - $461
-3 Reduced 0.14%
2,191 $294,000
Q2 2022

Aug 26, 2022

BUY
$137.62 - $174.96 $1,789 - $2,274
13 Added 0.6%
2,194 $336,000
Q1 2022

Aug 26, 2022

BUY
$131.98 - $163.75 $25,604 - $31,767
194 Added 9.76%
2,181 $353,000
Q4 2021

Aug 15, 2022

BUY
$107.43 - $135.93 $213,463 - $270,092
1,987 New
1,987 $269,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track W Advisors, LLC Portfolio

Follow W Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of W Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on W Advisors, LLC with notifications on news.